News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement Todd Neale March 20, 2025
News Daily News Cannabis Use Again Tied to Increased CVD Risk in Young People L.A. McKeown March 19, 2025
News Daily News AHA Offers Help for Clinicians Weighing the Results of DTC Genetic Tests Yael L. Maxwell March 18, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Daily News Food Insecurity in Adulthood Signals Greater Risk of Later CVD Todd Neale March 12, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Daily News Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD Michael O'Riordan March 06, 2025
News Daily News Patchy Anticoagulation Use During COVID Pandemic Raises Questions L.A. McKeown March 06, 2025
News Daily News Orthopedic and Radiation Injuries Unchanged in Cath Lab Staff Since 2014 L.A. McKeown March 05, 2025
News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News Veterans Health System Meets—or Bests—Community Care for CVD Caitlin E. Cox March 03, 2025
News Daily News Survey Calls Out Implicit Bias in Peripheral Vascular Care L.A. McKeown February 28, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2025 Shelley Wood February 28, 2025
News Daily News GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm Caitlin E. Cox February 26, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025